SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-071114
Filing Date
2019-12-10
Accepted
2019-12-09 20:39:55
Documents
2
Period of Report
2019-12-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1924846d1_8k.htm 8-K 24025
2 EXHIBIT 4.1 tm1924846d1_ex4-1.htm EX-4.1 34493
  Complete submission text file 0001104659-19-071114.txt   59853
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35112 | Film No.: 191276383
SIC: 2836 Biological Products, (No Diagnostic Substances)